• Topics
    • AI & Big Data
    • AR & VR
    • Blockchain
    • Clean Technology
    • Content & Games
    • Cybersecurity
    • Enterprise & SaaS
    • FinTech
    • Gadgets & Electronics
    • Health & Bio
    • IoT
    • Marketplaces & E-commerce
    • Robotics
    • Transportation & Logistics
    • Investments
    • Ecosystem & Lists
  • Interviews
  • Events
    • ComeUp
    • NextRise
  • Governments
    • KISA
    • KISED
    • KOCCA
    • KOTRA
    • MSS
    • NIPA
    • SBA
  • Programs
    • LAUNCHPAD
    • COMEUP STARS 120
    • K-Startup Grand Challenge
    • TIPS X beSUCCESS Global Project
  • Investment Opportunities
    • Launchpad France Demoday
    • TIPS Global Demoday
    • Launchpad USA Demoday
    • Launchpad Indonesia Demoday
  • Submit an Article
  • Forums
  • register
  • login
Wednesday, January 20, 2021
KoreaTechDesk
No Result
View All Result
Koreatechdesk
No Result
View All Result
Home Programs COMEUP STARS 120

Korean Startup J&T Biotech develops self-use auto-injector for allergy medication

 886 total views,  13 today views

Be one of the first to comment
James Jung by James Jung (KoreaTechDesk Writer)
PUBLISHED: December 22, 2020 UPDATED: January 4, 2021
in COMEUP STARS 120, Health & Bio, Programs, Startup
0
Bookmark(0)

Please login to bookmark

No account yet? Register

Korean Startup J&T Biotech develops self-use auto-injector for allergy medication

Korean startup J&T Biotech's self-injectable device – ‘Epitoc.'

0
SHARES
443
VIEWS
Share on FacebookShare on Twitter

READ ALSO

Call for applications for CANnovate 2021 – Devless Heroes, the global no-code startup acceleration program

Korean startups making healthcare rehabilitation better with technology 

There is a rise in demand for home medication solutions in the Coronavirus era. More and more people prefer tele-medicine or self-medication for manageable ailments like allergies, diabetes, hormone therapy, etc. Korean startup J&T Biotech has pioneered in bringing in self-injectable device – ‘Epitoc’, which is designed to allow patients to inject themselves. It is primarily used to treat patients with acute allergic reactions such as anaphylaxis. 

Founded in June 2020 by CEO Jeong Ryul Ryu and three other founders, the medi-tech startup is keen to pursue its unchanging values and wants to continually challenge the future and be a company for the new world post-COVID 19 era.

Epitoc – easy to use automatic syringe 

The startup’s prime product Epitoc is an acute allergy syringe containing epinephrine, a sympathetic nerve stimulant, used to treat a patient suffering from a reaction as an emergency. Epitoc is an automatic syringe that allows the patient to inject himself or others around him. The epinephrine auto-injector is exclusively supplied to the domestic market with a product imported overseas, “Zechst.” In the epinephrine auto-injector market that relies on XEXT, Epitoc has been developed to improve public health by stably supplying pharmaceuticals through the development of auto-injectors and domestic production for the first time in Korea. Epitoc’s primary consumers are emergency anaphylaxis patients, medical and public institutions, and military units requiring emergency treatment and disease prevention. 

Product expansion for other ailments

Based on the success of the development of Epitoc, the company plans to expand its pharmaceutical products so that they can apply automatic syringes to other drugs. J&T Biotech will provide an automatic injection solution specialized for each disease for diseases that depend on injection treatment, such as diabetes, osteoporosis, and autoimmune diseases. The startup plans to diversify auto-injector products by establishing a convenient drug delivery system for drugs with periodic demand for injections such as coronavirus and hormone therapy.  

“In particular, it is said Epitoc is also excellent in timeliness because it supports remote medical treatment, which has increased necessity due to the Corona 19 pandemic. It enables patients to directly administer therapeutic drugs and vaccinations for infectious diseases without the medical staff’s direct help. You can. In the future Era of telemedicine, I believe that automatic syringes will be a necessary drug delivery platform for self-drug treatment through remote medical examination” CEO Jeong Ryul Ryu.

Company expansion plans

The spread of allergic diseases is a worldwide trend. As of 2015, the global epinephrine auto-injector market is estimated to be approximately 2 trillion won or $ 184 billion, and it is still growing. The startup has applied for the recruitment of startup companies in preliminary startup packages supervised by the Ministry of SMEs and Startups. It has already signed a formal agreement with the company and is receiving a project cost of 44 million won or about $40k. Based on the domestic market’s success, J&T Biotech plans to promote Epitoc to the world, including China, by expanding overseas patent applications. In particular, the company intends to preoccupy the auto-injector market by rapidly advancing into China, where the bio-industry has started to snowball. It has already completed a provisional patent application for the Epitoc technology. J&T Biotech launched its mock-up product in October 2020 after completing its design, operation tests, and 3D prototype production.

Also read,

  • Korean startup MediHub’s ‘smart injector’ i-JECT makes dental anesthesia pain free
  • JUVIC: Injection Needles that won’t hurt
  • Korean startup InHandPlus’ smartwatch makes medication adherence easier 
  • Korean startup LOKKS307’s blockchain driven platform ‘DoseEase’ makes clinical trial data management easy & secure
What’s your thoughts?
+1
0
Upvote
+1
0
Clap
+1
0
Clap
+1
1
On fire
+1
0
Meh
+1
0
Clap
+1
0
Tags: AllgeriesAuto InjectorCOMEUP STARSEpitocJ&T BiotechMedicine
James Jung

James Jung

James Jung is a Senior Technology Reporter for KoreaTechDesk.

Related Posts

Call for applications for CANnovate 2021 – Devless Heroes, the global no-code startup acceleration program#Programs
Programs

Call for applications for CANnovate 2021 – Devless Heroes, the global no-code startup acceleration program

January 19, 2021
Korean startups making healthcare rehabilitation better with technology #Ecosystem & Lists
Ecosystem & Lists

Korean startups making healthcare rehabilitation better with technology 

January 11, 2021
Electronic contract platform FirmaChain announces partnership with NEST Protocol Oracle solution#Blockchain
Blockchain

Electronic contract platform FirmaChain announces partnership with NEST Protocol Oracle solution

January 6, 2021
Vietnamese startup Loship upgrades the customer experience game by combining food delivery and podcasts#Startup
Startup

Vietnamese startup Loship upgrades the customer experience game by combining food delivery and podcasts

January 4, 2021
Korean startup Neofect: Helping millions avail easy rehabilitation with smart therapeutic wearable devices#Health & Bio
Health & Bio

Korean startup Neofect: Helping millions avail easy rehabilitation with smart therapeutic wearable devices

January 3, 2021
Have you checked the success of this Korean ‘Start-up’ in 2020? #Entertainment
Entertainment

Have you checked the success of this Korean ‘Start-up’ in 2020? 

January 4, 2021
0 0 vote
Article Rating
Subscribe
Sign up Login
Notify of
Please login to comment
0 Comments
Inline Feedbacks
View all comments

FREE NEWSLETTER

No Result
View All Result

TRENDING POSTS

  • Vietnamese startup Loship upgrades the customer experience game by combining food delivery and podcasts

     911 total views,  8 today views

  • Korean startup Twinny Robotics’ autonomous navigation robots help logistics companies reduce cost and save time 

     1,393 total views,  11 today views

  • Korean startup Letsee to launch a global version of Web-AR solution

     843 total views,  6 today views

  • Korean startup IMEMINE CEO Iksoo Park about how the SizeMine app will help fashion e-commerce reduce returns cost

     827 total views,  13 today views

  • Korean startup Riiid’s AI Education Challenge attracts over 2,700 teams around the world

     906 total views,  6 today views

  • Korean Startup J&T Biotech develops self-use auto-injector for allergy medication

     886 total views,  13 today views

  • Korean Startup Seoul Robotics’ 3D engine for Lidar sensors to make autonomous driving smarter 

     670 total views,  6 today views

  • Korean startup Vogo safeguarding environment with its eco-friendly vessels for the marine industry

     768 total views,  4 today views

  • Korean startup Neofect: Helping millions avail easy rehabilitation with smart therapeutic wearable devices

     435 total views,  8 today views

  • Korean startup Exosystems makes smart knee care solution Exo-Rehab for elderly

     601 total views,  6 today views

More from our network


  • ktd

  • atd

  • itd

  • ktt

  • kgd

  • kpp

  • ktp

  • kpoppost

  • ustechtimes
  • About Us
  • Account
  • Account
  • Alertme test
  • Ask Question
  • Connections
  • Cookie-policy
  • Dashboard
  • dashboard
  • DWQA User Profile
  • Edit
  • Edit Company
  • Edit Company
  • edit form 5
  • edit form 8 copy testing page
  • Events
  • Followers
  • Followers
  • Following
  • Following
  • for_companies carousal
  • homepage
  • Investment Opportunities
  • Investment Opportunities test
  • Investment Opportunities with filter
  • judges
  • login
  • Login
  • Logout
  • Logout
  • mailchimp
  • Member Directory
  • Member Directory
  • Mentors Community
  • My Bookmarks
  • my companies
  • My Points
  • My Saved Deals
  • Newsletter
  • Order Received
  • Payment
  • poll test
  • post submitted
  • Privacy Policy
  • profile
  • Questions
  • register
  • Registration
  • Sample Page
  • Sitemap html
  • Sponsorships
  • Submit post
  • Submit your Startup Profile here
  • Subscription
  • team memeber
  • Terms of Use
  • test
  • test
  • testdate
  • Thank You
  • Time Zone Test
  • TIPS X beSUCCESS KOREAN STARTUP SHOWCASE
  • User login
  • wp forms add company
  • you want to logout?

Copyright © 2020 KoreaTechDesk | About Us | Sponsorships| Terms of Use |Privacy Policy |Cookie Policy Contact : press@koreatechdesk.com

No Result
View All Result
  • Topics
    • AI & Big Data
    • AR & VR
    • Blockchain
    • Clean Technology
    • Content & Games
    • Cybersecurity
    • Enterprise & SaaS
    • FinTech
    • Gadgets & Electronics
    • Health & Bio
    • IoT
    • Marketplaces & E-commerce
    • Robotics
    • Transportation & Logistics
    • Investments
    • Ecosystem & Lists
  • Interviews
  • Events
    • ComeUp
    • NextRise
  • Governments
    • KISA
    • KISED
    • KOCCA
    • KOTRA
    • MSS
    • NIPA
    • SBA
  • Programs
    • LAUNCHPAD
    • COMEUP STARS 120
    • K-Startup Grand Challenge
    • TIPS X beSUCCESS Global Project
  • Investment Opportunities
    • Launchpad France Demoday
    • TIPS Global Demoday
    • Launchpad USA Demoday
    • Launchpad Indonesia Demoday
  • Submit an Article
  • Forums
  • register
  • login

Copyright © 2020 KoreaTechDesk | About Us | Sponsorships| Terms of Use |Privacy Policy |Cookie Policy Contact : press@koreatechdesk.com

wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply

Insert/edit link

Enter the destination URL

Or link to existing content

    No search term specified. Showing recent items. Search or use up and down arrow keys to select an item.